RA

Rosalind Advisors Portfolio holdings

AUM $207M
This Quarter Return
+8.64%
1 Year Return
+62.29%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$207M
AUM Growth
+$207M
Cap. Flow
-$1.6M
Cap. Flow %
-0.77%
Top 10 Hldgs %
63.59%
Holding
43
New
4
Increased
7
Reduced
9
Closed
6

Top Buys

1
CYTK icon
Cytokinetics
CYTK
$13.2M
2
RZLT icon
Rezolute
RZLT
$7.77M
3
CGON icon
CG Oncology
CGON
$5.02M
4
DCTH icon
Delcath Systems
DCTH
$4M
5
FENC icon
Fennec Pharmaceuticals
FENC
$2.18M

Top Sells

1
ABEO icon
Abeona Therapeutics
ABEO
$8.6M
2
URGN icon
UroGen Pharma
URGN
$5.58M
3
NUVB icon
Nuvation Bio
NUVB
$4.31M
4
IDYA icon
IDEAYA Biosciences
IDYA
$3.97M
5
VSTM icon
Verastem
VSTM
$2.49M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
TLPH icon
26
Talphera
TLPH
$11.2M
$922K 0.44%
2,003,939
– –
BFRI icon
27
Biofrontera
BFRI
$9.28M
$695K 0.33%
976,448
+332,055
+52% +$236K
KURA icon
28
Kura Oncology
KURA
$732M
$577K 0.27%
100,000
– –
OVID icon
29
Ovid Therapeutics
OVID
$94.6M
$165K 0.08%
+500,000
New +$165K
ACOG
30
Alpha Cognition Inc. Common Stock
ACOG
$132M
– –
-104,836
Closed -$530K
ATYR
31
aTyr Pharma
ATYR
$560M
– –
0
– –
XNTK icon
32
SPDR NYSE Technology ETF
XNTK
$1.24B
– –
0
– –
SPY icon
33
SPDR S&P 500 ETF Trust
SPY
$656B
– –
0
– –
QQQ icon
34
Invesco QQQ Trust
QQQ
$364B
– –
0
– –
OPTN
35
DELISTED
OptiNose
OPTN
– –
-256,190
Closed -$2.35M
NUVB icon
36
Nuvation Bio
NUVB
$1.08B
– –
-2,451,500
Closed -$4.31M
LXRX icon
37
Lexicon Pharmaceuticals
LXRX
$392M
– –
0
– –
KPRX icon
38
Kiora Pharmaceuticals
KPRX
$9.61M
– –
-250,059
Closed -$753K
INMB icon
39
INmune Bio
INMB
$52.4M
– –
0
– –
CRNX icon
40
Crinetics Pharmaceuticals
CRNX
$3.26B
– –
0
– –
COGT icon
41
Cogent Biosciences
COGT
$1.83B
– –
-248,285
Closed -$1.49M
CADL icon
42
Candel Therapeutics
CADL
$281M
– –
0
– –
ABEO icon
43
Abeona Therapeutics
ABEO
$356M
– –
-1,805,817
Closed -$8.6M
1
2